n.c_trader
Long

EGRX LOW RISK AND HIGHT REWARD

NASDAQ:EGRX   EAGLE PHARMACEUTICALS INC
36 1 2
EGRX             broke another key resistance zone , it is in a nice zone to a long entry.

And today:
Eagle Pharmaceuticals             , Inc. (Nasdaq:EGRX) today announced that the 505(b)(2) New Drug Application (NDA) for its novel ready-to-use bivalirudin product (“RTU bivalirudin”) has been accepted for filing by the U.S. Food and Drug Administration (FDA).

http://finance.yahoo.com/news/eagle-pharmaceuticals-rtu-bivalirudin-nda-110000493.html
I wish I had found this stock a long time ago! That is some rally this year! $20 to $92 already. It looks like a lot of this news may already be in the stock? What's the risk here?
Reply
United States
United Kingdom
India
Deutschland
España
France
Việt Nam
Italia
Polska
Brasil
Россия
Türkiye
Indonesia
Malaysia
日本
한국
简体
繁體
Home Stock Screener Forex Signal Finder Cryptocurrency Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing Support Priority Support Report Issue Ideas Published Followers Following Private Messages Chat Sign Out